Agency Information Collection Activities; Proposed Collection; Comment Request; Sanitary Transportation of Human and Animal Food, 10369-10371 [2022-03916]
Download as PDF
Federal Register / Vol. 87, No. 37 / Thursday, February 24, 2022 / Notices
jspears on DSK121TN23PROD with NOTICES1
431.428 and in accordance with a
framework to be provided by CMS. The
STCs also provide that the monitoring
framework be subject to change as
monitoring systems are developed and
evolve, and that states are required to
report in a structured manner that
supports federal tracking and analysis.
In this 2022 information collection
request, we have revised the following
monitoring tools:
• Monitoring protocol tools:
Æ Monitoring protocol workbook
(updated to Version 6.0)
Æ Monitoring protocol template
(updated to Version 4.0)
• Monitoring report tools:
Æ Monitoring report template
(updated to Version 4.0)
Æ Monitoring report workbook
(updated to Version 6.0)
This 2022 release incorporates
updated guidance on reporting metrics,
narrative information, and other
clarifications. This release also reflects
modifications to align with the
Medicaid Section 1115 Substance Use
Disorder Demonstrations: Technical
Specifications for Monitoring Metrics
Manual Version 4.0 (released September
2021).
In addition, this release incorporates
updated functionality in the
Performance Metrics Database &
Analytics (PMDA) system aimed to
automate aspects of reporting and
customize tools to ease state burden.
Updated functionality includes:
• Auto-population of certain fields
within the monitoring report tools in
alignment with the state’s CMSapproved monitoring protocol.
• Reporting flagged items early in the
process to reduce resubmission and
allow CMS to engage with the state
faster and on a more detailed level.
• Ensuring the latest version of the
monitoring tools are utilized by sending
an email notification to all designated
demonstration contacts when
customized monitoring report tools are
available.
Form Number: CMS–10398 (#57)
(OMB control number: 0938–1148);
Frequency: Once, yearly, and quarterly;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
35; Total Annual Responses: 596; Total
Annual Hours: 6,394. For policy
questions regarding this collection
contact: Danielle Daly at 410–786–0897.
Dated: February 18, 2022.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2022–03936 Filed 2–23–22; 8:45 am]
BILLING CODE 4120–01–P
VerDate Sep<11>2014
16:46 Feb 23, 2022
Jkt 256001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0013]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Sanitary
Transportation of Human and Animal
Food
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA, Agency, or we) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection requirements associated with
the sanitary transportation of human
and animal food.
DATES: Submit either electronic or
written comments on the collection of
information by April 25, 2022.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before April 25,
2022. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of April 25, 2022. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
10369
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2013–N–0013 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request; Sanitary
Transportation of Human and Animal
Food.’’ Received comments, those filed
in a timely manner (see ADDRESSES),
will be placed in the docket and, except
for those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
E:\FR\FM\24FEN1.SGM
24FEN1
10370
Federal Register / Vol. 87, No. 37 / Thursday, February 24, 2022 / Notices
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–5733, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3521), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Sanitary Transportation of Human
and Animal Food—21 CFR Part 1,
Subpart O
OMB Control Number 0910–0773—
Extension
This information collection supports
FDA regulations regarding the sanitary
transportation of human and animal
food. The regulations are intended to
focus on preventing food safety
problems throughout the food chain and
were issued under the Sanitary Food
Transportation Act of 2005 (2005
SFTA), and the FDA Food Safety
Modernization Act, enacted in 2011.
The 2005 SFTA amended the Federal
Food, Drug, and Cosmetic Act (FD&C
Act), in part, by creating section 416 (21
U.S.C. 350e), which directs us to issue
regulations to require shippers, carriers
by motor vehicle or rail vehicle,
receivers, and other persons engaged in
the transportation of food to use
prescribed sanitary transportation
practices to ensure that food is not
transported under conditions that may
render the food adulterated. Section 416
also directs that we prescribe
appropriate human and animal food
transportation practice requirements
relating to: (1) Sanitation; (2) packaging,
isolation, and other protective measures;
(3) limitations on the use of vehicles; (4)
information to be disclosed to carriers
and to manufacturers; and (5)
recordkeeping.
In addition, the 2005 SFTA created
section 402(i) of the FD&C Act (21
U.S.C. 342(i)), which provides that food
that is transported or offered for
transport by a shipper, carrier by motor
vehicle or rail vehicle, receiver, or any
other person engaged in the
transportation of food under conditions
that are not in compliance with the
regulations issued under section 416 is
adulterated and section 301(hh) of the
FD&C Act (21 U.S.C. 331(hh)), which
prohibits the failure by a shipper, carrier
by motor vehicle or rail vehicle,
receiver, or any other person engaged in
the transportation of food to comply
with the regulations issued under
section 416.
The 2005 SFTA also amended section
703 of the FD&C Act (21 U.S.C. 373) by
providing that a shipper, carrier by
motor vehicle or rail vehicle, receiver,
or other person subject to section 416
shall, on request of an officer or
employee designated by FDA, permit
the officer or employee, at reasonable
times, to have access to and to copy all
records that are required to be kept
under the regulations issued under
section 416.
Accordingly, we issued regulations in
21 CFR part 1, subpart O (21 CFR 1.900
through 1.934) that establish
requirements for the sanitary
transportation of human and animal
food, as well as prescribe procedures for
respondents who wish to request a
waiver for any requirement. For
additional information regarding
Agency implementation of the SFTA,
visit our website at https://www.fda.gov/
food/guidance-documents-regulatoryinformation-topic-food-and-dietarysupplements/sanitation-transportationguidance-documents-regulatoryinformation.
We estimate the burden of the
information collection as follows:
TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
Number of
recordkeepers
21 CFR section; activity
jspears on DSK121TN23PROD with NOTICES1
1.912; Record retention ........................................
1 There
Number of
records per
recordkeeper
1,502,032
1
Total annual
records
1,502,032
Average burden per
recordkeeping
0.083 (5 minutes) .........
Total hours
124,669
are no capital costs or operating and maintenance costs associated with this collection of information.
We estimate an annual recordkeeping
burden of 124,669, which assumes
1,502,032 workers will spend an average
of 5 minutes on activities related to the
VerDate Sep<11>2014
16:46 Feb 23, 2022
Jkt 256001
record retention requirements under 21
CFR 1.912. We expect these activities
will likely include documenting
procedures and training, as well as
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
sanitary transportation operations and
specification requirements.
E:\FR\FM\24FEN1.SGM
24FEN1
10371
Federal Register / Vol. 87, No. 37 / Thursday, February 24, 2022 / Notices
TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1
1.914; Waiver petitions ........................................................
1 There
Number of
responses per
respondent
Number of
respondents
21 CFR section; activity
2
Average
burden per
response
Total annual
responses
1
2
24
Total hours
48
are no capital costs or operating and maintenance costs associated with this collection of information.
We estimate one waiver petition from
each of two firms will be submitted and
respondents will spend 24 hours to
prepare and submit the petition to FDA.
TABLE 3—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN 1
Number of
respondents
21 CFR section; activity
1.908; Disclosure of sanitary specifications;
operating temperature conditions.
1 There
Dated: February 16, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–03916 Filed 2–23–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2020–N–2252]
Final Assessment of the Program for
Enhanced Review Transparency and
Communication in the Biosimilar User
Fee Act; Public Meeting; Request for
Comments
Food and Drug Administration,
HHS.
Notice of public meeting;
request for comments.
ACTION:
The Food and Drug
Administration (FDA, the Agency, or
we) is announcing the following virtual
public meeting entitled ‘‘Final
Assessment of the Program for
Enhanced Review Transparency and
Communication in the Biosimilar User
Fee Act (BsUFA)’’ (the Program) and an
opportunity for public comment. The
topics to be discussed are the final
assessment and public stakeholder
views of the Program.
SUMMARY:
jspears on DSK121TN23PROD with NOTICES1
226
Total annual
disclosures
1
226
Average burden per
disclosure
0.5833 (∼35 minutes) ...........
Total hours
132
are no capital costs or operating and maintenance costs associated with this collection of information.
Finally, we estimate an annual thirdparty disclosure burden of 132 hours,
assuming each of 226 firms will spend
an average of 35 minutes, annually,
disclosing written records as required
under 21 CFR 1.908.
Based on an evaluation of the
information collection, we have made
no adjustments to our burden estimate.
AGENCY:
Number of
disclosures
per
respondent
VerDate Sep<11>2014
17:29 Feb 23, 2022
Jkt 256001
The public meeting will be held
on March 22, 2022, from 9:30 a.m. to
12:30 p.m. Eastern Time and will be
held by webcast only. Submit either
electronic or written comments on this
public meeting by May 23, 2022. See the
SUPPLEMENTARY INFORMATION section for
registration date and information.
ADDRESSES: Registration to attend the
meeting and other information can be
found at https://www.eventbrite.com/e/
public-meeting-on-the-final-assessmentof-the-bsufa-ii-program-tickets229459628927.
You may submit comments as
follows. Please note that late, untimely
filed comments will not be considered.
Electronic comments must be submitted
on or before May 23, 2022. The https://
www.regulations.gov electronic filing
system will accept comments until
11:59 p.m. Eastern Time at the end of
May 23, 2022. Comments received by
mail/hand delivery/courier (for written/
paper submissions) will be considered
timely if they are postmarked or the
delivery service acceptance receipt is on
or before that date.
DATES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2020–N–2252 for ‘‘Final Assessment of
the Program for Enhanced Review
Transparency and Communication in
the Biosimilar User Fee Act (BsUFA);
Public Meeting; Request for Comments.’’
Received comments, those filed in a
timely manner (see ADDRESSES), will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
E:\FR\FM\24FEN1.SGM
24FEN1
Agencies
[Federal Register Volume 87, Number 37 (Thursday, February 24, 2022)]
[Notices]
[Pages 10369-10371]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03916]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2013-N-0013]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Sanitary Transportation of Human and Animal Food
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA, Agency, or we) is
announcing an opportunity for public comment on the proposed collection
of certain information by the Agency. Under the Paperwork Reduction Act
of 1995 (PRA), Federal Agencies are required to publish notice in the
Federal Register concerning each proposed collection of information and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on the information collection requirements
associated with the sanitary transportation of human and animal food.
DATES: Submit either electronic or written comments on the collection
of information by April 25, 2022.
ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must be submitted on or before April 25, 2022. The https://www.regulations.gov electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of April 25, 2022. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are postmarked or the delivery service
acceptance receipt is on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2013-N-0013 for ``Agency Information Collection Activities;
Proposed Collection; Comment Request; Sanitary Transportation of Human
and Animal Food.'' Received comments, those filed in a timely manner
(see ADDRESSES), will be placed in the docket and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday, 240-402-7500.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you
[[Page 10370]]
must identify this information as ``confidential.'' Any information
marked as ``confidential'' will not be disclosed except in accordance
with 21 CFR 10.20 and other applicable disclosure law. For more
information about FDA's posting of comments to public dockets, see 80
FR 56469, September 18, 2015, or access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-5733,
[email protected].
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
Sanitary Transportation of Human and Animal Food--21 CFR Part 1,
Subpart O
OMB Control Number 0910-0773--Extension
This information collection supports FDA regulations regarding the
sanitary transportation of human and animal food. The regulations are
intended to focus on preventing food safety problems throughout the
food chain and were issued under the Sanitary Food Transportation Act
of 2005 (2005 SFTA), and the FDA Food Safety Modernization Act, enacted
in 2011. The 2005 SFTA amended the Federal Food, Drug, and Cosmetic Act
(FD&C Act), in part, by creating section 416 (21 U.S.C. 350e), which
directs us to issue regulations to require shippers, carriers by motor
vehicle or rail vehicle, receivers, and other persons engaged in the
transportation of food to use prescribed sanitary transportation
practices to ensure that food is not transported under conditions that
may render the food adulterated. Section 416 also directs that we
prescribe appropriate human and animal food transportation practice
requirements relating to: (1) Sanitation; (2) packaging, isolation, and
other protective measures; (3) limitations on the use of vehicles; (4)
information to be disclosed to carriers and to manufacturers; and (5)
recordkeeping.
In addition, the 2005 SFTA created section 402(i) of the FD&C Act
(21 U.S.C. 342(i)), which provides that food that is transported or
offered for transport by a shipper, carrier by motor vehicle or rail
vehicle, receiver, or any other person engaged in the transportation of
food under conditions that are not in compliance with the regulations
issued under section 416 is adulterated and section 301(hh) of the FD&C
Act (21 U.S.C. 331(hh)), which prohibits the failure by a shipper,
carrier by motor vehicle or rail vehicle, receiver, or any other person
engaged in the transportation of food to comply with the regulations
issued under section 416.
The 2005 SFTA also amended section 703 of the FD&C Act (21 U.S.C.
373) by providing that a shipper, carrier by motor vehicle or rail
vehicle, receiver, or other person subject to section 416 shall, on
request of an officer or employee designated by FDA, permit the officer
or employee, at reasonable times, to have access to and to copy all
records that are required to be kept under the regulations issued under
section 416.
Accordingly, we issued regulations in 21 CFR part 1, subpart O (21
CFR 1.900 through 1.934) that establish requirements for the sanitary
transportation of human and animal food, as well as prescribe
procedures for respondents who wish to request a waiver for any
requirement. For additional information regarding Agency implementation
of the SFTA, visit our website at https://www.fda.gov/food/guidance-documents-regulatory-information-topic-food-and-dietary-supplements/sanitation-transportation-guidance-documents-regulatory-information.
We estimate the burden of the information collection as follows:
Table 1--Estimated Annual Recordkeeping Burden 1
----------------------------------------------------------------------------------------------------------------
Number of Average burden
21 CFR section; activity Number of records per Total annual per Total hours
recordkeepers recordkeeper records recordkeeping
----------------------------------------------------------------------------------------------------------------
1.912; Record retention....... 1,502,032 1 1,502,032 0.083 (5 124,669
minutes).
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
We estimate an annual recordkeeping burden of 124,669, which
assumes 1,502,032 workers will spend an average of 5 minutes on
activities related to the record retention requirements under 21 CFR
1.912. We expect these activities will likely include documenting
procedures and training, as well as sanitary transportation operations
and specification requirements.
[[Page 10371]]
Table 2--Estimated Annual Reporting Burden 1
----------------------------------------------------------------------------------------------------------------
Number of
21 CFR section; activity Number of responses per Total annual Average burden Total hours
respondents respondent responses per response
----------------------------------------------------------------------------------------------------------------
1.914; Waiver petitions......... 2 1 2 24 48
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
We estimate one waiver petition from each of two firms will be
submitted and respondents will spend 24 hours to prepare and submit the
petition to FDA.
Table 3--Estimated Annual Third-Party Disclosure Burden 1
----------------------------------------------------------------------------------------------------------------
Number of
21 CFR section; activity Number of disclosures Total annual Average burden Total hours
respondents per respondent disclosures per disclosure
----------------------------------------------------------------------------------------------------------------
1.908; Disclosure of sanitary 226 1 226 0.5833 (~35 132
specifications; operating minutes).
temperature conditions.
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
Finally, we estimate an annual third-party disclosure burden of 132
hours, assuming each of 226 firms will spend an average of 35 minutes,
annually, disclosing written records as required under 21 CFR 1.908.
Based on an evaluation of the information collection, we have made
no adjustments to our burden estimate.
Dated: February 16, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-03916 Filed 2-23-22; 8:45 am]
BILLING CODE 4164-01-P